{"title":"Sex and Age-Based Differences in Adult Acute Myeloid Leukemia Hospitalizations in the United States, 2009-2018","authors":"Deepa Dongarwar, Karla Moriel, Kobby A. Wiafe, H. Salihu","doi":"10.21106/ijtmrph.402","DOIUrl":null,"url":null,"abstract":"Acute myeloid leukemia (AML) represents the fifth-worst five-year overall survival by cancer type in the United States, and the prognosis is shown to vary by age and sex. However, published data exploring temporal trends in the rates of hospitalization by sex and prognosis patterns incorporating both age and sex remains limited. Therefore, we investigated trends of acute myeloid leukemia (AML) hospitalization rates by sex and the differences in the AML hospitalization rates by sex and age in the adult population using the Nationwide Inpatient Sample database for the years 2009-2018. We examined the differences in rates of AML hospitalizations by sex and age. Next, we stratified the study duration into two groups of five years each: 2009-2013 and 2014-2018 and examined the differences in age and sex across the study period and groups. Pearson’s chi-squared tests were conducted to determine the statistically significant differences in these bivariate comparisons. Overall, during the entire study period, we observed an increased rate of hospitalizations in males, when compared with their female counterparts. The highest AML hospitalization rate for both males and females was observed in the age group of 60-79 years; males accounted for 33.8 per 10,000 hospitalizations and females accounted for 23.3 per 10,000 hospitalizations. The greatest difference in hospitalization rates by age group and sex was observed in 18-39 years (males: 23.6 per 10,000 hospitalizations, females: 7.7 per 10,000 hospitalizations [p-value=<0.01]). The trend in the prevalence of AML hospitalizations by age or sex remains unchanged irrespective of the 5-year study period group. The results from this study would prove vital in directing the decision-making process for healthcare providers and AML patients alike as they work in tandem to navigate the complexities of AML and everything it entails.\n \nCopyright © 2022 Dongarwar et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License CC BY 4.0.","PeriodicalId":93768,"journal":{"name":"International journal of translational medical research and public health","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of translational medical research and public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21106/ijtmrph.402","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
2009-2018年美国成人急性髓细胞白血病住院患者的性别和年龄差异
急性髓细胞白血病(AML)是美国癌症类型的五年或五年总生存率,其预后因年龄和性别而异。然而,已发表的研究按性别划分的住院率时间趋势和包括年龄和性别在内的预后模式的数据仍然有限。因此,我们使用2009-2018年全国住院患者样本数据库,调查了成年人群中急性髓细胞白血病(AML)住院率的性别趋势以及AML住院率的差异。我们研究了AML住院率的性别和年龄差异。接下来,我们将研究持续时间分为两组,每组五年:2009-2013年和2014-2018年,并检查了研究期间和各组的年龄和性别差异。进行皮尔逊卡方检验以确定这些双变量比较中的统计学显著差异。总体而言,在整个研究期间,我们观察到男性的住院率与女性相比有所上升。男性和女性AML住院率最高的是60-79岁年龄组;男性占住院人数的33.8%,女性占住院人数中的23.3%。18-39岁年龄组和性别的住院率差异最大(男性:每10000例住院23.6例,女性:每10000名住院7.7例[p值<0.01])。无论5年研究期组如何,按年龄或性别划分的AML住院率趋势保持不变。这项研究的结果将证明对指导医疗保健提供者和AML患者的决策过程至关重要,因为他们协同工作,应对AML的复杂性及其所需的一切。版权所有©2022 Dongarwar等人,由Global Health and Education Projects,股份有限公司出版。这是一篇根据知识共享署名许可CC by 4.0条款分发的开放获取文章。
本文章由计算机程序翻译,如有差异,请以英文原文为准。